首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1529558

無菌注射劑市場：依分子類型、藥物類型、適應症、給藥途徑及地區

Sterile Injectables Market, By Molecule Type, By Drug Type, By Disease Indication, By Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Others), By Geography

出版日期: 2024年07月19日 | 出版商:

Coherent Market Insights | 英文 197 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球無菌注射劑市場規模為5,861億美元，預計2031年將達9,841億美元，2024年至2031年複合年成長率為7.7%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	5861億美元
實際資料	2019-2023	預測期	2024-2031
2024-2031 年預測期複合年成長率	7.70%	2031 年金額預測	9841億美元

圖：2024 年按地區分類的無菌注射劑市場佔有率(%)

全球無菌注射劑市場的成長是由於慢性病盛行率上升以及全球老年人口越來越容易患此類疾病而推動的。無菌注射劑用於腫瘤學、自體免疫疾病、血液學、眼科和麻醉學等治療領域。此外，對生技藥品的需求不斷增加以及這些藥物的價格實惠正在推動市場成長。然而，與無菌注射劑生產相關的嚴格監管規範可能會阻礙預測期內的市場成長。

市場動態：

全球無菌注射劑市場的成長是由全球癌症和其他慢性疾病發生率上升所推動的。不斷成長的老年人口更容易患慢性病，也可能推動對無菌注射劑的需求。此外，生技藥品因其優越的功效而相對於傳統藥物越來越受歡迎，也可能提供新的市場成長機會。然而，由於監管機構實施嚴格的品管標準，與無菌注射劑相關的高製造成本可能會阻礙市場成長。由於製造過程中的污染問題而導致的產品召回可能會阻礙市場成長。開發有效生物相似藥的持續研發活動可能在不久的將來提供市場成長機會。

本研究的主要特點

該報告對全球無菌注射劑市場進行了詳細分析，並提供了以 2023 年為基準年的預測期（2024-2031 年）的市場規模（十億美元）和年複合成長率（CAGR%）。它。
它還說明了各個細分市場的潛在商機，並為該市場提供了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球無菌注射劑市場的主要企業。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球無菌注射劑市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過分析全球無菌注射劑市場時所使用的各種策略矩陣來促進決策。

公司簡介
- Pfizer Inc.
- Merck &Co., Inc.
- Johnson &Johnson
- Baxter International Inc.
- Novartis AG
- Sanofi SA
- GlaxoSmithKline plc（GSK）
- AstraZeneca PLC
- Gilead Sciences, Inc.
- Amgen Inc.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Fresenius SE &Co. KGaA（Fresenius Kabi）
- Becton, Dickinson and Company（BD）
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company

第12章分析師建議

上升和下降
綜合機會圖

第13章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI201

Global sterile injectables market is estimated to be valued at USD 586.1 Bn in 2024 and is expected to reach USD 984.1 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 586.1 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	7.70%	2031 Value Projection:	US$ 984.1 Bn

Figure. Sterile Injectables Market Share (%), By Region 2024

Global sterile injectables market growth is driven by rising incidence of chronic diseases along with growing geriatric population worldwide who are more susceptible to such diseases. Sterile injectables are used in therapeutic areas like oncology, autoimmune diseases, hematology, ophthalmology, anesthesia, and others. Moreover, rising demand for biologics and affordability of these drugs can drive the market growth. However, stringent regulatory norms associated with sterile injectables production can hamper the market growth during the forecast period.

Market Dynamics:

Global sterile injectables market growth is driven by growing incidence of cancer and other chronic diseases globally. Growing geriatric population prone to chronic medical conditions can also boost demand for sterile injectables. Moreover, rising popularity of biologics over conventional drugs due to superior efficacy can offer new market growth opportunities. However, high production costs associated with sterile injectables due to stringent quality control standards imposed by regulatory authorities can hamper the market growth. Product recalls owing to contamination issues during manufacturing can hamper the market growth. Ongoing R&D activities for developing effective biosimilars can offer market growth opportunities in the near future.

Key Features of the Study:

This report provides in-depth analysis of the global sterile injectables market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook and competitive strategies adopted by key players.
It profiles key players in the global sterile injectables market based on the following parameters - company highlights, products portfolio, key highlights, financial performance and strategies.
Key companies covered as a part of this study include Pfizer Inc., Baxter International Inc., Abbott Laboratories and GlaxoSmithKline plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion and marketing tactics.
Global sterile injectables market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sterile injectables market

Detailed Segmentation-

By Molecule Type
- Large Molecules
- Small Molecule
By Drug Type
- Monoclonal Antibodies
- Cytokines
- Insulin
- Peptide Hormones
- Blood Factors
- Vaccines
- Immunoglobulins
- Peptide Antibiotics
- Others
By Disease Indication
- Cancer
- Diabetes
- Cardiovascular Disorders
- Musculoskeletal Disorders
- CNS disorders
- Infectious Disorders
- Others
By Route of Administration
- Intravenous (IV)
- Intramuscular (IM)
- Subcutaneous (SC)
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Pfizer Inc.
- Merck & Co., Inc.
- Johnson & Johnson
- Baxter International Inc.
- Novartis AG
- Sanofi S.A.
- GlaxoSmithKline plc (GSK)
- AstraZeneca PLC
- Gilead Sciences, Inc.
- Amgen Inc.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Fresenius SE & Co. KGaA (Fresenius Kabi)
- Becton, Dickinson and Company (BD)
- Hoffmann-La Roche Ltd
- Eli Lilly and Company

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Molecule Type
- Market Snapshot, By Drug Type
- Market Snapshot, By Disease Indication
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Sterile Injectables Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Sterile Injectables Market, By Molecule Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Large Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Small Molecule
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Sterile Injectables Market, By Drug Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Monoclonal Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cytokines
- Mammography
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Insulin
- Chest X-ray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Peptide Hormones
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Blood Factors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Vaccines
- Mammography
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Immunoglobulins
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Peptide Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Sterile Injectables Market, By Disease Indication, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiovascular Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Musculoskeletal Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
CNS disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Infectious Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Sterile Injectables Market, By Route of Administration, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intramuscular
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Subcutaneous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Sterile Injectables Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

10. Global Sterile Injectables Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
Asia Pacific
Middle East

11. Competitive Landscape

Company Profiles
- Pfizer Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
- Johnson & Johnson
- Baxter International Inc.
- Novartis AG
- Sanofi S.A.
- GlaxoSmithKline plc (GSK)
- AstraZeneca PLC
- Gilead Sciences, Inc.
- Amgen Inc.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Fresenius SE & Co. KGaA (Fresenius Kabi)
- Becton, Dickinson and Company (BD)
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company